Cancer Diagnostic Study for Dogs with Suspected Hemangiosarcoma or Mammary Carcinoma
At MedVet Columbus and MedVet Indianapolis
MedVet is currently enrolling dogs in a multi-center research study investigating the feasibility of a new cancer diagnostic test. Sponsor is requesting one peripheral blood sample prior to tumor removal. Owners must allow the biopsy results to be shared with the sponsor. Patients will be evaluated by the appropriate specialty department to confirm eligibility.
Patients must meet the following criteria:
- Dogs must display clinical signs of Hemangiosarcoma or Mammary Carcinoma (excluding spayed females for suspected mammary carcinoma cases)
- Patients must be tumor bearing
- Not currently being treated for cancer
- Planning or willing to have tumor section removed for histopathology analysis
The sponsor will pay $200 towards the owner’s invoice for tumor biopsy or removal.
Primary Study Contacts: